Research by Joel Cantor et al. “Access to Hepatitis C Treatment during and after Incarceration in New Jersey, United States: A Qualitative Study”

April 17, 2023

Abstract

Despite effective antiviral therapy for hepatitis C virus (HCV), people who are incarcerated and those returning to the community face challenges in obtaining HCV treatment. We aimed to explore facilitators and barriers to HCV treatment during and after incarceration. From July–November 2020 and June–July 2021, we conducted 27 semi-structured interviews with residents who were formerly incarcerated in jail or prison. The interviews were audio-recorded and professionally transcribed. We used descriptive statistics to characterize the study sample and analyzed qualitative data thematically using an iterative process. Participants included five women and 22 men who self-identified as White (n = 14), Latinx (n = 8), and Black (n = 5). During incarceration, a key facilitator was having sufficient time to complete HCV treatment, and the corresponding barrier was delaying treatment initiation. After incarceration, a key facilitator was connecting with reentry programs (e.g., halfway house or rehabilitation program) that coordinated the treatment logistics and provided support with culturally sensitive staff. Barriers included a lack of insurance coverage and higher-ranking priorities (e.g., managing more immediate reentry challenges such as other comorbidities, employment, housing, and legal issues), low perceived risk of harm related to HCV, and active substance use. Incarceration and reentry pose distinct facilitators and challenges to accessing HCV treatment. These findings signal the need for interventions to improve engagement in HCV care both during and after incarceration to assist in closing the gap of untreated people living with HCV.

Keywords: HCV; Hepatitis C; treatment; direct-acting antiviral DAA; prison; jail; incarceration; linkage to care; qualitative

Citation

Kamat, Samir, Sankeerth Kondapalli, Shumayl Syed, Gabrielle Price, George Danias, Ksenia Gorbenko, Joel Cantor, Pamela Valera, Aakash K. Shah, and Matthew J. Akiyama. 2023. “Access to Hepatitis C Treatment during and after Incarceration in New Jersey, United States: A Qualitative Study” Life 13, no. 4: 1033. https://doi.org/10.3390/life13041033

Recent Posts

Mi Shih Recognized with GPEIG Best Journal Article Award

Mi Shih, Ph.D., Associate Professor and director of the Urban Planning and Policy Development Program, was recognized with the Global Planning Educators’ Interest Group’s (GPEIG) 2025 award for the best journal article. The award honors outstanding, peer-reviewed...

Building Capacity to Support New Jersey Autism Professionals

Building Capacity to Support New Jersey Autism Professionals: A Workforce Study and Multi-state Comparative Landscape of Policies and Practices Daniel Rosario, Josephine O’Grady, Lily McFarland, Peter Walter, Ryne Kremer, Sean Nguyen, and Wun-cian Lin for Autism New...

Dr. Rushing Talks About AI for Sickle Cell and Beyond

Dr. Melinda Rushing recently appeared on the podcast Zora Talks. In this podcast, Dr. Rushing breaks down what sickle cell really is, why it disproportionately affects people of color, and how her team is developing a new approach called Clinically Guided AI to...

NJSPL: Increasing Enrollment of Paid Family Leave

The Increasing Enrollment of Paid Family Leave for Parents in the U.S. Over the past 10 years, many U.S. states have implemented mandatory paid family leave policies to help address the lack of such policy on the national level. In this post, we examine how paid...